Stock Analysis
Data Source: SEC EDGAR 13F
Updated Hourly

Tenax Therapeutics Inc (TENX)

78 + Investors. Track Smart Money conviction in TENX. See who's accumulating, reducing, or initiating positions.

Current Price
-- USD
Analyst Target
-- (0 analysts)
Upside
0.00%
Net Flow Q/Q
↑ +31
Streak
9Q ▲
Buyers last Q
87%

Smart Money Signals — TENX

Based on 78 hedge funds · latest filing: 2026 Q1 · updated quarterly

📈

Buying streak — 9 quarters in a row

last 6Q
For 9 consecutive quarters, more hedge funds added TENX than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.
🏔️

At the ownership peak (100% of max)

100% of all-time peak
78 hedge funds hold TENX right now — the highest count in 3.0 years. When ownership is this concentrated, any bad news can trigger a chain reaction: one big fund sells, others follow. This is a classic 'crowded trade' — high popularity doesn't equal safety.
🚀

Fast accumulation — +239% more funds vs a year ago

fund count last 6Q
+55 new funds entered over the past year (+239% YoY). That's a rapid rush of institutional money. Fast accumulation often signals a major thesis — but it also means the stock could fall quickly if that thesis breaks.
🟢

More buyers than sellers — 87% buying

58 buying9 selling
Last quarter: 58 funds were net buyers (33 opened a brand new position + 25 added to an existing one). Only 9 were sellers (7 trimmed + 2 sold completely). A clear majority buying is a strong confirmation signal.
📈

More new buyers each quarter (+15 vs last Q)

new funds entering per quarter
Funds opening a new TENX position: 2 → 11 → 18 → 33. A growing influx of new institutional buyers means the asset is still gathering momentum — the consensus hasn't fully saturated yet.
🔄

Mostly new holders — 65% entered in last year

■ 6% conviction (2yr+) ■ 28% medium ■ 65% new
Only 5 funds (6%) have held >2 years. The majority of current holders are relatively new to the position. New holders tend to sell faster when prices drop — a shallow conviction base that could amplify any sell-off.
💰

Value +248% but shares only +208% — price-driven

Value
+247%
Shares
+208%
Last quarter: the total dollar value of institutional holdings rose +248%, but actual share count only changed +208%. The gap is explained by the stock's price rising — not new buying. Strong value growth with weak share growth means the rally is price momentum, not fresh institutional demand.
🚀

Acceleration phase — new buyers rushing in

4 → 2 → 11 → 18 → 33 new funds/Q
New funds entering each quarter: 2 → 11 → 18 → 33. The pace of institutional discovery is accelerating sharply. This is the 'hot idea' phase — the thesis is being passed from fund to fund. You are not late — the accumulation wave is still building.
🌱

Early stage — 68% of holders entered in last year

■ 2% veterans ■ 30% 1-2yr ■ 68% new
Of 80 current holders: 54 (68%) entered in the past year, only 2 (2%) are 2+ year veterans. This is an early-phase institutional idea — still being discovered. High upside potential if the thesis plays out, but thin conviction base.
✅

Strong quality — 27% AUM from major funds

27% from top-100 AUM funds
22 of 78 holders rank in the top 100 by AUM, accounting for 27% of total institutional value held. A meaningful share of the ownership value comes from the most well-resourced institutions.
6.6
out of 10
Moderate Exit Risk
Exit risk score 6.6/10 — some crowding factors present, but no critical concentration. Watch ownership trend over the next 1–2 quarters for direction.

Methodology note: these Smart Money cards use consecutive 13F disclosure snapshots, not trade-by-trade execution data. "Buying", "selling", "new holders", and "trimmed" refer to quarter-over-quarter changes in reported holders, aggregate shares, or disclosed position values between filings. They are useful for ownership regime analysis and crowding, but they do not imply exact trade timing on the filing date.

Institutional Sentiment Summary — TENX

In 2026 Q1, 58 hedge funds were net buyers of TENX (33 opened a new position, 25 added to an existing one), while 9 reduced or exited (7 trimmed, 2 sold completely) — a 87% buyer ratio, indicating clear institutional accumulation. This marks 9 consecutive quarters of net institutional buying — a persistent conviction signal. 27% of total institutional value in TENX is held by top-100 AUM funds, reflecting strong institutional quality. Net fund flow last quarter: +31 funds (more new holders than closures). Total institutional holders: 78.

Hedge Fund Ownership: TENX

How many hedge funds hold TENX — quarterly history vs. share price
Quarterly hedge fund ownership of TENX vs. share price

Market Analysis: TENX

Analyst Price Targets

Avg. Price Target
--

Analyst Recommendations

Stock Performance

Real-time

Company Profile: TENX

-- --

Institutional ownership data sourced from SEC EDGAR Form 13F-HR filings.

Loading signal freshness…
Smart Money Signal ?
Limited Smart Money Interest

No strong consensus or elite conviction detected among institutional holders.

6 top-rated funds 1 high-conviction
Consensus
3.7
/ 10
breadth
×
Elite
1.8
/ 10
conviction
Hedge Fund Positioning: TENX
2026 Q2 Stats Unlock in 4 days 78 + Investors

Track Smart Money conviction in TENX. See who's accumulating, reducing, or initiating positions.

Metric All 13F Filers (2026 Q1) Prior (2025 Q4) Change
Funds Holding 78 47 65.96%
13F Shares 21M 7M 208.3%
Total Value $295M $85M 247.8%
New Positions 33 18 +15
Increased Positions 25 12 +13
Closed Positions 2 5 -3
Reduced Positions 5 3 +2
Total Calls 2 0 100%
Total Puts 0 0 -
PUT/CALL Ratio 0.0 0.0 Bullish

Statistics: TENX

View More

Valuation Measures Data as of: --

Market Cap --
Enterprise Value --
Trailing P/E --
Forward P/E --
PEG Ratio (5yr expected) --
Price/Sales (ttm) --
Price/Book (mrq) --
Enterprise Value/Revenue --
Enterprise Value/EBITDA --
Beta (5Y Monthly) --
Short Ratio (Days to Cover) --
Short % of Float --

Financial Highlights

Profitability
Profit Margin --
Return on Assets (ttm) --
Return on Equity (ttm) --
Income Statement & Cash Flow
Revenue (ttm) --
Net Income Avi to Common (ttm) --
Diluted EPS (ttm) --
Total Cash (mrq) --
Total Debt/Equity (mrq) --
Levered Free Cash Flow (ttm) --

Institutional Holders (2026 Q2)

78 + investors

Explore institutional interest and hedge fund ownership dynamics. Analyze portfolio weights, new positions, and conviction trends in TENX. Verified SEC 13F-HR filings.

QUARTER:
2026 Q2 filings are still coming in. Only funds that have filed so far are shown — top holders may not have reported yet. Full 13F data typically settles by ~50 days after quarter-end.
Top 25 TENX holders by conviction (% of portfolio weight) — 2026 Q1 · Source: SEC Form 13F
# Investor % of Portfolio Shares Mkt Value
1 Velan Capital Investment Management LP 4.87% 549,985 $8.0M
2 Stonepine Capital Management, LLC 4.50% 660,000 $9.6M
3 Vivo Capital, LLC 3.32% 2,500,000 $36.4M
4 Verdad Advisers, LP 1.72% 123,174 $1.8M
5 Ikarian Capital, LLC 1.23% 787,600 $11.5M
6 Avidity Partners Management LP 0.62% 265,934 $3.9M
7 Velan Capital Investment Management LP 0.61% 68,700 $1000K
8 Ikarian Capital, LLC 0.58% 373,100 $5.4M
9 Diadema Partners LP 0.56% 307,000 $4.5M
10 Creek Drive Management Group LLC 0.52% 74,000 $1.1M
11 Sofinnova Investments, Inc. 0.38% 500,039 $7.3M
12 Perceptive Advisors LLC 0.37% 1,700,000 $24.7M
13 Braidwell LP 0.31% 584,412 $8.5M
14 Sphera Funds Management LTD. 0.24% 127,600 $1.9M
15 Stempoint Capital LP 0.24% 96,273 $1.4M
16 Sphera Funds Management LTD. 0.23% 120,200 $1.7M
17 Logos Global Management LP 0.19% 300,000 $4.4M
18 Tetragon Partners GP Ltd 0.17% 75,100 $1.1M
19 ADAR1 Capital Management, LLC 0.15% 220,462 $3.2M
20 Bvf Inc/Il 0.13% 339,549 $4.9M
21 Siren, L.L.C. 0.13% 427,141 $6.2M
22 Landscape Capital Management, L.L.C. 0.12% 132,272 $1.9M
23 Artia Global Partners LP 0.11% 42,080 $612K
24 Integral Health Asset Management, LLC 0.10% 167,000 $2.4M
25 Rtw Investments, LP 0.09% 696,570 $10.1M
Investor Ownership
History 		% of Portfolio Prev % Rank Conviction Avg Buy Price 13F Score™ 3Y / 7Y Sell Timing Shares Mkt Value Change Change % Source Quarter Filed

Frequently Asked Questions — Tenax Therapeutics Inc (TENX)

What does the Smart Money Trend signal show for TENX?

Buying streak — 9 quarters in a row: For 9 consecutive quarters, more hedge funds added TENX than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.

What is the institutional breadth score for TENX?

More buyers than sellers — 87% buying: Last quarter: 58 funds were net buyers (33 opened a brand new position + 25 added to an existing one). Only 9 were sellers (7 trimmed + 2 sold completely). A clear majority buying is a strong confirmation signal.

What is the fund quality score for TENX holders?

Strong quality — 27% AUM from major funds: 22 of 78 holders rank in the top 100 by AUM, accounting for 27% of total institutional value held. A meaningful share of the ownership value comes from the most well-resourced institutions.

How long have hedge funds held TENX?

Mostly new holders — 65% entered in last year: Only 5 funds (6%) have held >2 years. The majority of current holders are relatively new to the position. New holders tend to sell faster when prices drop — a shallow conviction base that could amplify any sell-off.

Where does this institutional ownership data come from?

All holdings data is sourced from SEC Form 13F filings, which institutional investment managers with over $100 million in assets are required to submit quarterly. Data is parsed directly from SEC EDGAR.

Disclaimer: The information on this page is for informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any security. Institutional holdings data is sourced from SEC Form 13F filings and reflects positions as of the filing date. Past performance of any fund or portfolio is not indicative of future results. 13Foresight is not a registered investment adviser. Always conduct your own due diligence before making investment decisions.

Full history →